Thanks to CASAA, who are SRNT members, I have now seen the full study.
For me there are several interesting elements. The peak plasma nic levels seen are over 20ng/ml (and after over an hour's vaping) although most users measured less. All used their own mods / e-cigs and their own liquid, albeit in cartos as that was a requirement of the study. Since they could vape as needed, however they liked, the result is substantially equivalent to real-life use.
Perhaps if allowed to use tanks and liquid feed arrangements, the nic levels would have been a fraction higher. On the other hand, if the vapers tested could have previously experimented at length with the carts/cartos arrangement required, they would then have raised the nic strength of the liquid used, to get the same result. They used, on average, 18mg strength liquid, which we would consider average. There are several strengths available retail above and below that.
This is a useful study which enters into the literature a simple fact that any experienced vaper knows: e-cigarettes work. It has to be remembered, though that something doesn't 'exist' for medics unless doctors have measured it themselves and it has been published.
The whole business of funding a trial, writing the protocols, arranging staff and facilities, running the trials, organising the results, writing up the results, getting the methodology checked and approved, submission for publication, and finally seeing it in print, is a major enterprise. When finally we see something done right, at considerable expense in time and energy, not to mention cost, we should applaud it.
(As a practical-minded person {read: mean} I see one rather nice advantage of this study, for the organisers / grant managers - the subjects brought their own equipment. What a model
)
Now we come to the obligatory closing line, so beloved of researchers, and traditionally such agony for us. It often comes in a form such as, "We have thus shown that e-cigarettes work. However further research is needed, and until then, see your doctor for FDA-approved medications if you want to quit". There is so much wrong with that typical finisher that the reader cries with frustration. Luckily, this time, we have been spared too much pain - instead of a 10 on the pain scale we are down to around a 4. This is progress.
"One important potential benefit of EC regulation may be more consistent nicotine delivery, device performance, and cartridge and vapor content."
For medics, this is shows unbelievable restraint. The fact that it is still partly in cloud-cuckoo land is not their fault, they deal with medical matters, not the reality of politics and money. Unfortunately, FDA regulation = removal of as much as possible from the market by any means possible that will survive legal challenge. It's what they're paid to do by their owners.
The perfect result in the FDA's eyes would be three e-cigs left on the market, none of which works properly. Anyway, leaving that aside, it is easy to see a situation in which mini e-cigs are plentiful, and can be shown not to work for beginners, in terms of nicotine delivery. That after all is normal. If in fact 'consistent nicotine delivery' and 'device performance', as measured by plasma nic levels as that is the only viable test, is a regulatory factor in any way, then the current nic strengths in cartos will have to go way up.
If you are selling minis to newbies, and the regulations say you can/should be seeing reasonable plasma nic levels, then 18mg and 24mg refills (1.8% and 2.4%) aren't going to cut the mustard. Not only will you need to supply 36mg (3.6%), but maybe even 48mg (4.8%), in order that the poor device performance plus the poor user technique of naive users does actually produce measurable blood nicotine levels.
Some new users will be OK on 5ng plasma levels, and some will need 30ng/ml. Given there is a factor-10 difference in individual tolerance to nicotine, there will be a percentage of users needing 48mg nic liquid to show any useful range of results, when using a mini e-cig.